$BLFS
BIOLIFE SOLUTIONS INC

2017 Q3 Form 10-Q Financial Statement

#000143774918020089 Filed on November 08, 2018

View on sec.gov

Income Statement

Concept 2017 Q3
Revenue $2.963M
YoY Change 38.79%
Cost Of Revenue $1.096M
YoY Change 18.98%
Gross Profit $1.868M
YoY Change 53.81%
Gross Profit Margin 63.02%
Selling, General & Admin $1.607M
YoY Change -13.38%
% of Gross Profit 86.04%
Research & Development $293.1K
YoY Change -41.01%
% of Gross Profit 15.69%
Depreciation & Amortization $80.00K
YoY Change -20.0%
% of Gross Profit 4.28%
Operating Expenses $1.900M
YoY Change -19.22%
Operating Profit -$32.35K
YoY Change -97.16%
Interest Expense $1.077K
YoY Change -96.77%
% of Operating Profit
Other Income/Expense, Net -$286.4K
YoY Change 123.53%
Pretax Income -$318.7K
YoY Change -74.9%
Income Tax
% Of Pretax Income
Net Earnings -$318.7K
YoY Change -67.11%
Net Earnings / Revenue -10.76%
Basic Earnings Per Share -$0.03
Diluted Earnings Per Share -$0.03
COMMON SHARES
Basic Shares Outstanding 13.24M
Diluted Shares Outstanding 13.24M

Balance Sheet

Concept 2017 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.800M
YoY Change 100.0%
Cash & Equivalents $2.831M
Short-Term Investments
Other Short-Term Assets $300.0K
YoY Change -25.0%
Inventory $1.900M
Prepaid Expenses
Receivables $1.355M
Other Receivables $0.00
Total Short-Term Assets $6.400M
YoY Change 28.0%
LONG-TERM ASSETS
Property, Plant & Equipment $1.100M
YoY Change -15.38%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $1.400M
YoY Change
Other Assets $0.00
YoY Change
Total Long-Term Assets $2.500M
YoY Change -56.9%
TOTAL ASSETS
Total Short-Term Assets $6.400M
Total Long-Term Assets $2.500M
Total Assets $8.900M
YoY Change -17.59%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $400.0K
YoY Change -63.64%
Accrued Expenses $500.0K
YoY Change 0.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.100M
YoY Change -68.57%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities $51.24K
YoY Change -92.68%
Total Long-Term Liabilities $51.24K
YoY Change -92.68%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.100M
Total Long-Term Liabilities $51.24K
Total Liabilities $1.700M
YoY Change -63.04%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $7.200M
YoY Change
Total Liabilities & Shareholders Equity $8.900M
YoY Change -17.59%

Cashflow Statement

Concept 2017 Q3
OPERATING ACTIVITIES
Net Income -$318.7K
YoY Change -67.11%
Depreciation, Depletion And Amortization $80.00K
YoY Change -20.0%
Cash From Operating Activities $70.00K
YoY Change -107.95%
INVESTING ACTIVITIES
Capital Expenditures -$10.00K
YoY Change -95.0%
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities -$10.00K
YoY Change -95.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 450.0K
YoY Change -60.18%
NET CHANGE
Cash From Operating Activities 70.00K
Cash From Investing Activities -10.00K
Cash From Financing Activities 450.0K
Net Change In Cash 510.0K
YoY Change 920.0%
FREE CASH FLOW
Cash From Operating Activities $70.00K
Capital Expenditures -$10.00K
Free Cash Flow $80.00K
YoY Change -111.76%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2018Q3 blfs Amortization Of Deferred Rent
AmortizationOfDeferredRent
31749
blfs Amortization Of Deferred Rent
AmortizationOfDeferredRent
95248
CY2017Q3 blfs Amortization Of Deferred Rent
AmortizationOfDeferredRent
31749
blfs Amortization Of Deferred Rent
AmortizationOfDeferredRent
95249
CY2018Q3 blfs Class Of Warrant Or Right Exercised During Period
ClassOfWarrantOrRightExercisedDuringPeriod
557153
blfs Class Of Warrant Or Right Exercised During Period
ClassOfWarrantOrRightExercisedDuringPeriod
2382844
CY2018Q3 blfs Class Of Warrant Or Right Exercised During Period Exercise Price
ClassOfWarrantOrRightExercisedDuringPeriodExercisePrice
4.75
blfs Class Of Warrant Or Right Exercised During Period Exercise Price
ClassOfWarrantOrRightExercisedDuringPeriodExercisePrice
4.75
blfs Increase Decrease In Deferred Rent
IncreaseDecreaseInDeferredRent
-11490
blfs Increase Decrease In Deferred Rent
IncreaseDecreaseInDeferredRent
-63836
CY2018Q3 blfs Landlordfunded Leasehold Improvements Accumulated Amortization
LandlordfundedLeaseholdImprovementsAccumulatedAmortization
724773
CY2017Q4 blfs Landlordfunded Leasehold Improvements Accumulated Amortization
LandlordfundedLeaseholdImprovementsAccumulatedAmortization
629525
CY2018Q3 blfs Landlordfunded Leasehold Improvements Gross
LandlordfundedLeaseholdImprovementsGross
1124790
CY2017Q4 blfs Landlordfunded Leasehold Improvements Gross
LandlordfundedLeaseholdImprovementsGross
1124790
CY2018Q3 blfs Landlordfunded Leasehold Improvements Net
LandlordfundedLeaseholdImprovementsNet
400017
CY2017Q4 blfs Landlordfunded Leasehold Improvements Net
LandlordfundedLeaseholdImprovementsNet
495265
blfs Legals Fees For Private Equity Transaction Incurred But Not Yet Paid
LegalsFeesForPrivateEquityTransactionIncurredButNotYetPaid
42500
blfs Legals Fees For Private Equity Transaction Incurred But Not Yet Paid
LegalsFeesForPrivateEquityTransactionIncurredButNotYetPaid
blfs Payments On Equipment Financing
PaymentsOnEquipmentFinancing
9267
blfs Payments On Equipment Financing
PaymentsOnEquipmentFinancing
10628
blfs Proceeds From Exercise Of Common Stock Options And Warrants
ProceedsFromExerciseOfCommonStockOptionsAndWarrants
11724247
blfs Proceeds From Exercise Of Common Stock Options And Warrants
ProceedsFromExerciseOfCommonStockOptionsAndWarrants
784273
blfs Receivables Converted To Equity Investment
ReceivablesConvertedToEquityInvestment
150103
blfs Receivables Converted To Equity Investment
ReceivablesConvertedToEquityInvestment
CY2018Q3 blfs Straightline Rent Adjustment
StraightlineRentAdjustment
116312
CY2017Q4 blfs Straightline Rent Adjustment
StraightlineRentAdjustment
127158
CY2018Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
1089553
CY2017Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
690702
CY2018Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2699342
CY2017Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1021315
CY2018Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
162981
CY2017Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
200548
CY2018Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2234286
CY2017Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2008927
CY2018Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
115775040
CY2017Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
84036444
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1130945
CY2018Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
383140
CY2017Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
313943
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1130945
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
957711
CY2018Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0
CY2017Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
5575
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
155996
CY2018Q3 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
CY2017Q3 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
CY2018Q3 us-gaap Assets
Assets
46448976
CY2017Q4 us-gaap Assets
Assets
12143203
CY2018Q3 us-gaap Assets Current
AssetsCurrent
38288948
CY2017Q4 us-gaap Assets Current
AssetsCurrent
9930881
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
49101
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
52327
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6663318
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1405826
CY2018Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
32380674
CY2017Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2830541
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
25717356
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
1424715
CY2018Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
4.37
CY2017Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
4.50
CY2018Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
4306005
CY2017Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
6688849
CY2018Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2017Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2017Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2018Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2017Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2018Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
18237425
CY2017Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
14021422
CY2018Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
18237425
CY2017Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
14021422
CY2018Q3 us-gaap Common Stock Value
CommonStockValue
18237
CY2017Q4 us-gaap Common Stock Value
CommonStockValue
14021
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Concentrations of credit risk and business risk</div></div></div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">&nbsp;</div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">In the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">nine</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2018, </div>we derived approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">41%</div> of our product revenue from <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> customers and approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">28%</div> of our revenue from <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">two</div> customers, respectively. In the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">nine</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2017, </div>we derived approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">22%</div> of our product revenue from <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">two</div> customers and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10%</div> of our product revenue from <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> customer, respectively. <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No</div> other customer accounted for more than <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10%</div> of revenue in the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">nine</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2018 </div>or <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017.</div> At <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2018, </div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">four</div> customers accounted for approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">54%</div> of total gross accounts receivable. At <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2017, </div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">two</div> customers accounted for approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">41%</div> of total gross accounts receivable.</div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">&nbsp;</div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">Revenue from customers located in foreign countries represented <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8%</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10%</div> of total revenue during the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">nine</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2018, </div>respectively, and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">16%</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">17%</div> during the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">nine</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2017, </div>respectively. All revenue from foreign customers is denominated in United States dollars.</div></div></div>
CY2018Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1606303
CY2017Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1095724
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
4506911
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2980965
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
4250000
CY2018Q3 us-gaap Deferred Rent Credit
DeferredRentCredit
516329
CY2017Q4 us-gaap Deferred Rent Credit
DeferredRentCredit
622423
CY2018Q3 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
130216
CY2017Q4 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
130216
CY2018Q3 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
386113
CY2017Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
492207
CY2018Q3 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
36166
CY2017Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
36166
us-gaap Depreciation
Depreciation
244927
us-gaap Depreciation
Depreciation
259895
CY2018Q3 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
79675
CY2017Q3 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
106250
us-gaap Dividends Preferred Stock
DividendsPreferredStock
279183
CY2018Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.07
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.16
CY2018Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
712615
CY2017Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
491432
CY2018Q3 us-gaap Equity Method Investments
EquityMethodInvestments
6856980
CY2017Q4 us-gaap Equity Method Investments
EquityMethodInvestments
1070120
CY2017Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.13
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.16
CY2018Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.05
CY2017Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.10
CY2018Q3 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
705948
CY2017Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
682466
CY2018Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1454573
CY2017Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1118251
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4198474
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3298461
CY2018Q3 us-gaap Gross Profit
GrossProfit
3686772
CY2017Q3 us-gaap Gross Profit
GrossProfit
1867687
us-gaap Gross Profit
GrossProfit
9778900
us-gaap Gross Profit
GrossProfit
4906412
CY2018Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1230769
CY2017Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-318718
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2373429
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1957220
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-363243
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-707208
CY2018Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-42689
CY2017Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-217735
CY2017Q4 us-gaap Liabilities
Liabilities
2050617
CY2018Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
46448976
CY2017Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
12143203
CY2018Q3 us-gaap Liabilities Current
LiabilitiesCurrent
2095365
CY2017Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1512898
CY2018Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
CY2017Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
342875
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-227732
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1678027
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
159851
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
204653
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
138885
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
152143
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1064181
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
103274
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
48606
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
101479
CY2018Q3 us-gaap Interest Expense
InterestExpense
1313
CY2017Q3 us-gaap Interest Expense
InterestExpense
1077
us-gaap Interest Expense
InterestExpense
3545
us-gaap Interest Expense
InterestExpense
188992
CY2018Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
910967
CY2017Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
810040
CY2018Q3 us-gaap Inventory Net
InventoryNet
2910927
CY2017Q4 us-gaap Inventory Net
InventoryNet
1846746
CY2018Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
1168969
CY2017Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
582816
CY2018Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
830991
CY2017Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
453890
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
71250
CY2018Q3 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
1284491
CY2017Q4 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
1284491
CY2018Q3 us-gaap Liabilities
Liabilities
2519333
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
2094246
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2063470
CY2017Q3 us-gaap Operating Expenses
OperatingExpenses
1900032
us-gaap Operating Expenses
OperatingExpenses
7159411
us-gaap Operating Expenses
OperatingExpenses
5743999
CY2018Q3 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
0
CY2017Q4 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
0
CY2018Q3 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
1510729
CY2017Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
1148006
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
30293904
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1714047
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-6339068
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-91443
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1762520
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-197889
us-gaap Net Income Loss
NetIncomeLoss
2373429
us-gaap Net Income Loss
NetIncomeLoss
-1957220
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
1230769
CY2017Q3 us-gaap Net Income Loss
NetIncomeLoss
-318718
CY2018Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1151094
CY2017Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-424968
CY2018Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
35771
CY2017Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-286373
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-246060
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1119633
us-gaap Notes Issued1
NotesIssued1
17604
us-gaap Notes Issued1
NotesIssued1
39243
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2018Q3 us-gaap Operating Expenses
OperatingExpenses
2491774
CY2018Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
1194998
CY2017Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-32345
us-gaap Operating Income Loss
OperatingIncomeLoss
2619489
us-gaap Operating Income Loss
OperatingIncomeLoss
-837587
CY2018Q3 us-gaap Other Income
OtherIncome
79773
CY2017Q3 us-gaap Other Income
OtherIncome
103
us-gaap Other Income
OtherIncome
120728
us-gaap Other Income
OtherIncome
227
CY2018Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
37855
CY2017Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
45512
us-gaap Payment Of Financing And Stock Issuance Costs
PaymentOfFinancingAndStockIssuanceCosts
42500
us-gaap Payment Of Financing And Stock Issuance Costs
PaymentOfFinancingAndStockIssuanceCosts
9303
us-gaap Payments For Repurchase Of Redeemable Preferred Stock
PaymentsForRepurchaseOfRedeemablePreferredStock
1063000
us-gaap Payments For Repurchase Of Redeemable Preferred Stock
PaymentsForRepurchaseOfRedeemablePreferredStock
us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
305758
us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
42664
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
6000000
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
339068
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
91443
CY2018Q3 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
79675
CY2017Q3 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
106250
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
279183
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
106250
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
1000000
CY2018Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2017Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2018Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2017Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2018Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
3187
CY2017Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
4250
CY2018Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
3187
CY2017Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
4250
CY2018Q3 us-gaap Preferred Stock Value
PreferredStockValue
3
CY2017Q4 us-gaap Preferred Stock Value
PreferredStockValue
4
CY2018Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
298005
CY2017Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
399502
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
19999994
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
CY2018Q3 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
2600000
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
11300000
CY2018Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3501168
CY2017Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3114963
CY2018Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1266882
CY2017Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1106036
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
9812
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
7631
CY2018Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
312000
CY2017Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
293093
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
983066
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
898451
CY2018Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-71863637
CY2017Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-73957883
CY2018Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
5293075
CY2017Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
2963411
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
14285811
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
7887377
CY2018Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
725201
CY2017Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
488688
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1977871
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1547087
us-gaap Share Based Compensation
ShareBasedCompensation
1130945
us-gaap Share Based Compensation
ShareBasedCompensation
957711
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
21128
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
3.32
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
181268
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
7.02
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
237926
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
301473
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
1.79
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
4.82
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
96593
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
1.80
us-gaap Stock Issued1
StockIssued1
35625
us-gaap Stock Issued1
StockIssued1
35624
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
35625
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
19914994
us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
11724247
us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
1063000
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
10092586
CY2018Q3 us-gaap Stockholders Equity
StockholdersEquity
43929643
CY2018Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
6383221
CY2017Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
5522193
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
CY2018Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
23656633
CY2017Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13238248
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
21051219
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13102238
CY2018Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17273412
CY2017Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13238248
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15529026
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13102238
us-gaap Write Off Of Deferred Debt Issuance Cost
WriteOffOfDeferredDebtIssuanceCost
us-gaap Write Off Of Deferred Debt Issuance Cost
WriteOffOfDeferredDebtIssuanceCost
67664
CY2018Q3 us-gaap Write Off Of Deferred Debt Issuance Cost
WriteOffOfDeferredDebtIssuanceCost
CY2017Q3 us-gaap Write Off Of Deferred Debt Issuance Cost
WriteOffOfDeferredDebtIssuanceCost
67664

Files In Submission

Name View Source Status
R41.htm Edgar Link pending
0001437749-18-020089-index-headers.html Edgar Link pending
0001437749-18-020089-index.html Edgar Link pending
0001437749-18-020089.txt Edgar Link pending
0001437749-18-020089-xbrl.zip Edgar Link pending
al1.jpg Edgar Link pending
bioli20180930_10q.htm Edgar Link pending
blfs-20180930.xml Edgar Link completed
blfs-20180930.xsd Edgar Link pending
blfs-20180930_cal.xml Edgar Link unprocessable
blfs-20180930_def.xml Edgar Link unprocessable
blfs-20180930_lab.xml Edgar Link unprocessable
blfs-20180930_pre.xml Edgar Link unprocessable
ex_128390.htm Edgar Link pending
ex_128391.htm Edgar Link pending
ex_128392.htm Edgar Link pending
ex_128393.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending